|
|
| Bone
Mass and OC Use |
|
| Studies Examining Association |
|
|
|
|
|
|
|
|
|
|
|
|
|
| n | 9/13 studies
show positive effects |
||||||||||
| n | Up to 12%
increase in BMD vs. control subjects |
||||||||||
| n | Greatest
protection with OC use of 10 y |
||||||||||
| n | Primarily an
estrogen effect; progestins |
||||||||||
| may be
important |
|||||||||||
| n | 4 studies show
neutral effect |
||||||||||
| n | No studies
show decreased BMD with OC use |
||||||||||
| Kuohung W et al. Contraception. 2000;61:77-82. |
